In the News

Share

Connect with us

Stay Informed.

Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
COVID-19: Information for Patients and Caregivers

We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.

What you need to know

1663 News Items found
In the Lab
Scott Lowe
SKI Scientists Solve 30-Year-Old Mystery About p53 Protein — Dubbed ‘Guardian of the Genome’

Rather than promoting genetic chaos, loss of p53 leads to an orderly progression of genetic changes that no one saw coming.
Dr. Bob Li
First Drug Targeting HER2-Mutant Non-Small Cell Lung Cancer Approved by FDA

The FDA has approved the drug trastuzumab deruxtecan for the treatment of advanced non-small cell lung cancer driven by mutant HER2. An MSK-led study published in September 2021 contributed to the drug's approval.
pancreatic surgeon and K12 alum Vinod Balachandran
MSK Program Prepares Clinicians for Careers in Translational Cancer Research

In the past 30 years, major strides have been made in translational medicine — the bridge that shepherds research findings from the lab to clinical practice. Researchers, physicians, and other specialists at Memorial Sloan Kettering Cancer Center (MSK) have played a major role in these successes, as they work together with the common goal of using their discoveries to create new treatments for people with cancer.
In the Clinic
Shanu Modi
FDA Approves First Targeted Drug To Treat HER2-Low Breast Cancer: Trastuzumab Deruxtecan (T-DXd)

On August 5, 2022, the FDA approved the first targeted therapy for patients with HER2-low breast cancer that has spread to other parts of the body and is unable to be surgically removed. The drug, trastuzumab deruxtecan (T-DXd), was approved based on a clinical trial led by Memorial Sloan Kettering Cancer Center (MSK) breast medical oncologist Shanu Modi.
Q&A
MSK medical oncologist Smita Joshi, who specializes in esophageal cancer.
Esophageal Cancer Risk: The Truth About Hot Drinks Like Coffee and Tea

There is very little evidence that drinking hot beverages increases esophageal cancer risk.
Man putting on sunscreen
Can Tattoos Hide Skin Cancer? Advice From MSK on How To Stay Safe

First, the good news: There’s no evidence that tattoos cause skin cancer, says Memorial Sloan Kettering Cancer Center (MSK) dermatologist Jennifer DeFa...
Memorial Sloan Kettering Cancer Center physician-scientist Richard Wong
Pancreatic Cancer Spreads With Help From Schwann Cells, MSK Researchers Find

Pancreatic cancer cells spread with the help of tracks laid by nerve-supporting cells called Schwann cells.
Feature
Memorial Sloan Kettering Cancer Center radiologist Sandra Brennan, Director of Radiology at MSK Westchester.
Common Breast Lumps That Aren’t Cancer

Learn about the different types of benign breast lumps.
bowl of edamame
Does Eating Soy Increase Estrogen and Cause Breast Cancer?

Learn whether eating soy products causes cancer.
Q&A
Medical oncologist Emily Feld
Metastatic and Metastasized Cancers: Answers to 7 Common Questions

In this Q&A, medical oncologist Emily Feld talks about how metastatic cancer is diagnosed and treated at MSK.